Dr. Reddy’s introduces azole antifungal tablets in U.S.
The Hindu
HYDERABAD
Drugmaker Dr. Reddy’s Laboratories has introduced Posaconazole Delayed-Release Tablets, 100 mg in the U.S.
An azole antifungal, the product is a therapeutic generic equivalent to Noxafil (posaconazole) Delayed-Release Tablets, 100 mg and has been introduced following U.S. Food and Drug Administration’s approval, the company said. It is indicated for prophylaxis of certain fungal infections in severely immunocompromised patients.
The Noxafil brand and generic had U.S. sales of approximately $140.8 million MAT for the most recent 12 months ended February 2022, Dr. Reddy’s said citing IQVIA numbers.
Beijing has asked some Chinese tech companies to halt orders for Nvidia’s H200 chips this week, and is expected to mandate domestic artificial intelligence chip purchases, the Information reported
Indian stock markets dip as foreign fund outflows and U.S. tariff concerns weigh on investor sentiment.
Elon Musk persuaded a judge on Wednesday to allow a jury trial on his allegations that ChatGPT maker OpenAI violated its founding mission
South Korean tech giant Samsung Electronics said Thursday it expected its fourth-quarter profit to reach a record 20 trillion won ($13.8 billion).
India's climate progress shows reduced emissions intensity and increased renewable capacity, but absolute emissions remain high, requiring urgent action.
According to recent Foreign Trade Performance Analysis data, India’s overall exports remained resilient in late 2025, even as traditional sectors faced sharp declines. While shipments of gems and jewellery to the U.S. plummeted, the overall figures were bolstered by a massive 237% surge in telecom exports, particularly smartphones. Data shows that Indian exporters are aggressively diversifying their portfolios. By deepening ties with existing partners and discovering new alliances, India is replacing lost U.S. sales with a more diversified set of trade partners
Agnivesh Agarwal, son of billionaire Anil Agarwal, dies at 49 after a skiing accident and subsequent cardiac arrest.
Infosys partners with AWS to enhance generative AI adoption, transforming operations and innovation across multiple industries.
India requests fare data from airlines amid IndiGo's antitrust investigation following widespread flight cancellations and disruptions.
Despite severe air pollution, Delhi remains the top choice for high-value homebuyers, including HNIs and celebrities.
Centre invites public feedback on the draft Pesticides Management Bill, 2025, aiming to replace the 1968 Insecticides Act.
India's wind energy capacity reached 54.51 GW in 2025, marking an 85.4% increase from the previous year.
The government forecasts a 7.4% GDP growth for 2025-26, highlighting sector-specific trends and anticipated slowdowns in the second half.